8-KThe WireRoutine
Bylaw Amendment · Shareholder Vote
Filed Jun 29, 2023 · 3y ago · Accession 0000950170-23-030725
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Trevi Therapeutics, Inc.
- Ticker
- TRVI
- CIK
- 1563880
- Form type
- 8-K
- Filing date
- Jun 29, 2023
- Report date
- Jun 28, 2023
- Document
- trvi-20230628.htm
- Size
- 242 KB